Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage forms

Peer Review reports

Original Submission
7 Jan 2023	Submitted	Original manuscript
31 Jan 2023	Reviewed	Reviewer Report - Pritam S. Jain
20 Feb 2023	Reviewed	Reviewer Report
3 Mar 2023	Author responded	Author comments - Galal Magdy
Resubmission - Version 2
3 Mar 2023	Submitted	Manuscript version 2
Publishing
14 Apr 2023	Editorially accepted
5 May 2023	Article published	10.1186/s13065-023-00955-w

Back to article page